Targeting Fibrosis
Fibrosis is the pathological overaccumulation of excess connective tissue as a result of imbalances during the body’s healing processes [...]
An Overview of Multiplex Slide Imaging Approaches
Mike Johnson2020-12-29T14:40:46-05:00At Visikol, our core objective is to help service Clients and product Customers to transform their tissues into quantitative [...]
Come Visit Visikol at the College of American Pathologists at Booth #216
Mike Johnson2019-09-15T15:48:52-05:00This year’s College of American Pathologists annual meeting will take place in Orlando, Florida from September 21st to the [...]
Visikol Presents During Thermo Fisher’s 24 Days of Stem Cells on Oct 25th
Mike Johnson2019-09-12T11:11:23-05:00Make sure to register for Thermo Fisher’s 24 days of stem cells starting on October 1st. Each week during [...]
Using Multiplex Imaging and Digital Pathology for IO Therapeutics
Mike Johnson2019-10-02T19:32:57-05:00Over the last few years, the development of immuno-oncology therapeutics has been on the rise with many leading pharmaceutical [...]
Visikol Presents on 3D Cell Culture at the NIH
The last few years have been very exciting for cell biology and drug discovery in general with the application [...]
Visikol Publishes Tissue Clearing Ebook on 3D Tissue Imaging and Analysis
Over the last few years, the Visikol portfolio of tissue clearing reagents have been used by over a thousand [...]
How does Tissue Clearing work?
Mike Johnson2019-07-22T11:09:49-05:00A question we frequently receive from customers and other people interested in tissue clearing is a fundamental one: how [...]
Come Visit Visikol at ISSX in Portland at Booth #105
Mike Johnson2019-07-25T07:26:51-05:00Visikol will be in Portland this year at the 2019 ISSX conference on July 28th-31st. Come visit us at [...]
3D H&E of Thick FFPE Tissue Sections
Mike Johnson2019-07-22T15:12:51-05:00Visikol leverages its expertise in the field of advanced imaging and image analysis – with special emphasis on 3D [...]